COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES
Associate partner of UNESCO - in official relations with WHO.
The Council for International Organizations of Medical Sciences (CIOMS) is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949. CIOMS represents a substantial proportion of the biomedical scientific community through its member organizations, which include many of the biomedical disciplines, national academies of sciences and medical research councils. CIOMS mission is to advance public health through guidance on health research including ethics, medical product development and safety.
MoreCioms news
RECENT PUBLICATIONS
CIOMS has several new publications from our Working Groups.
Please visit shop
2016 year
2500 CHF FREE
CIOMS WORKING GROUPS
A broad range of drug safety topics are covered by CIOMS via working groups. Senior scientists from regulatory authorities, pharmaceutical industry and academia join together in order to develop consensus guidelines within areas such as international reporting of adverse drug reactions (ADRs) e.g. CIOMS I reporting form, periodic drug safety update summaries and development safety update report, core clinical safety information on drugs, terminology of ADRs, standardised MedDRA queries and pharmacogenetics.
There have also been joint working groups together with the World Health Organization covering drug development research and pharmacovigilance in resource-poor countries and vaccine pharmacovigilance.
The current and recent Working Groups
CIOMS MEETINGS
Upcoming Meetings
27 - 28 November 2018
Aix-en-Provence, France
4th meeting of Drug Induced Liver Injury Working Group
11 December 2018
Geneva, Switzerland
CIOMS 85th Executive Committee Meeting
27 - 28 February 2019
Geneva, Switzerland
4th meeting of Clinical Research in Resource-Limited Settings Working Group
02 - 03 April 2019
Geneva, Switzerland
15th Meeting of the Implementation Working Group on MedDRA
01 - 02 May 2019
Geneva, Switzerland
3rd Meeting Working Group XI Patient Involvement in Developmnt/Safe Use Medicines
Recent Meetings
Member Organizations
